Korean J Hepatol.  2009 Jun;15(2):227-230. 10.3350/kjhep.2009.15.2.227.

Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma

Affiliations
  • 1Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea. jheo@pusan.ac.kr

Abstract

No abstract available.

Keyword

Carcinoma, Hepatocellular; Tyrosine kinase inhibitor; Sorafenib

MeSH Terms

Adenosine Triphosphatases/*genetics
Amino Acid Substitution
Cation Transport Proteins/*genetics
Genotype
Haplotypes
Hepatolenticular Degeneration/diagnosis/*genetics
Humans
Mutation
Republic of Korea
Full Text Links
  • KJHEP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr